We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

157 hedge funds and large institutions have $1.59B invested in Arcus Biosciences in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 44 increasing their positions, 55 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more call options, than puts

Call options by funds: $23.4M | Put options by funds: $11.1M

79% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 19

33% more funds holding in top 10

Funds holding in top 10: 6 → 8 (+2)

11% more funds holding

Funds holding: 142 → 157 (+15)

1.11% less ownership

Funds ownership: 72.35% → 71.25% (-1.1%)

20% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 55

23% less capital invested

Capital invested by funds: $2.06B → $1.59B (-$468M)

Holders
157
Holders Change
+15
Holders Change %
+10.56%
% of All Funds
2.48%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.13%
New
34
Increased
44
Reduced
55
Closed
19
Calls
$23.4M
Puts
$11.1M
Net Calls
+$12.3M
Net Calls Change
+$15.5M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$34.4M
2
APM
Avidity Partners Management
Texas
+$30.6M
3
BI
BVF Inc
California
+$18.9M
4
State Street
State Street
Massachusetts
+$18.7M
5
PA
Perceptive Advisors
New York
+$13.6M

Top Sellers

1
EC
EcoR1 Capital
California
-$75.7M
2
WP
Woodline Partners
California
-$48.4M
3
Morgan Stanley
Morgan Stanley
New York
-$39.7M
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$15M
5
Franklin Resources
Franklin Resources
California
-$14.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Board of Administration of Florida Retirement System
101
State Board of Administration of Florida Retirement System
Florida
$536K -$91.5K -2,730 -14%
GCP
102
GSA Capital Partners
United Kingdom
$499K +$322K +9,599 +155%
Victory Capital Management
103
Victory Capital Management
Texas
$417K +$348K +10,384 +152%
Zurich Cantonal Bank
104
Zurich Cantonal Bank
Switzerland
$389K -$7.97K -238 -2%
TC
105
TwinBeech Capital
New York
$336K +$356K +10,635 New
BNP Paribas Financial Markets
106
BNP Paribas Financial Markets
France
$330K -$227K -6,789 -39%
ASRS
107
Arizona State Retirement System
Arizona
$330K -$4.19K -125 -1%
Hudson Bay Capital Management
108
Hudson Bay Capital Management
Connecticut
$316K +$335K +10,000 New
Ensign Peak Advisors
109
Ensign Peak Advisors
Utah
$312K – – –
PCA
110
Personal Capital Advisors
California
$297K – – –
DT
111
Diversified Trust
Tennessee
$285K – – –
Handelsbanken Fonder
112
Handelsbanken Fonder
Sweden
$268K -$127K -3,800 -31%
ProShare Advisors
113
ProShare Advisors
Maryland
$266K -$45.7K -1,365 -14%
Man Group
114
Man Group
United Kingdom
$265K -$359K -10,700 -56%
BAM
115
Blueshift Asset Management
New Jersey
$263K +$279K +8,327 New
Principal Financial Group
116
Principal Financial Group
Iowa
$262K -$8.98K -268 -3%
EFM
117
E Fund Management
China
$256K +$272K +8,105 New
ACM
118
Anfield Capital Management
California
$254K – – –
Janus Henderson Group
119
Janus Henderson Group
United Kingdom
$252K -$235 -7 -0.1%
Teacher Retirement System of Texas
120
Teacher Retirement System of Texas
Texas
$251K +$19.8K +590 +8%
WVP
121
Worth Venture Partners
New Jersey
$249K +$265K +7,900 New
MML Investors Services
122
MML Investors Services
Massachusetts
$245K -$175K -5,221 -40%
PHK
123
Point72 Hong Kong
Hong Kong
$245K +$245K +7,325 +1,631%
EWM
124
Empirical Wealth Management
Washington
$202K – – –
AB
125
Amalgamated Bank
New York
$171K -$14.4K -429 -7%
3 4
5
6 7

RCUS Hedge Fund Activity: Q1 2022 in Review

157 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q1 2022, worth a combined $1.59B — down 23% from $2.06B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new RCUS positions and 19 closed out — a net gain of 15 holders — while 44 added to existing stakes and 55 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $34.4M. The largest seller was EcoR1 Capital, cutting an estimated $75.7M.

  • 157 institutional investors held Arcus Biosciences (RCUS) as of Q1 2022, up from 142 in Q4 2021.
  • Funds reported $1.59B of Arcus Biosciences stock for Q1 2022, down 23% quarter-over-quarter.
  • 34 funds opened new Arcus Biosciences positions in Q1 2022 and 19 closed out, a net change of +15 holders.
  • The largest Arcus Biosciences buyer in Q1 2022 was AllianceBernstein, an estimated $34.4M added.
  • The largest Arcus Biosciences seller in Q1 2022 was EcoR1 Capital, an estimated $75.7M sold.

Based on aggregated 13F filings for Q1 2022.